bw a1433u has been researched along with adenosine in 15 studies
| Studies (bw a1433u) | Trials (bw a1433u) | Recent Studies (post-2010) (bw a1433u) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
|---|---|---|---|---|---|
| 26 | 0 | 0 | 32,536 | 1,075 | 8,930 |
| Protein | Taxonomy | bw a1433u (IC50) | adenosine (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
| Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 11 (73.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Q; Hauth, T; Hyman, A; Lippton, HL | 1 |
| Cahill, BE; Haile, DM; Kadowitz, PJ; Neely, CF | 1 |
| Carper, HT; Hewlett, EL; Hylton, JB; Linden, J; Mandell, GL; Sullivan, GW | 1 |
| Belardinelli, L; Froldi, G | 1 |
| Campochiaro, PA; Friedman, Z; Hackett, SF; Linden, J | 1 |
| Belardinelli, L; Wesley, RC | 1 |
| Cronin, MJ; Delahunty, TM; Linden, J | 1 |
| Belardinelli, L; Bourassa, A; Clemo, HF; Linden, J | 1 |
| Armstrong, S; Ganote, CE | 1 |
| Downey, JM; Liu, GS; Mullane, K; Olsson, RA; Richards, SC; Walsh, RS | 1 |
| Asimakis, GK; Conti, VR; Inners-McBride, K | 1 |
| Fralix, TA; London, RE; Murphy, E; Steenbergen, C | 1 |
| Lasley, RD; Mentzer, RM | 1 |
| Gabel, SA; London, RE; Murphy, E; O'Connell, TM | 1 |
| Hill, RJ; Magee, W; Masamune, H; Oleynek, JJ; Tracey, WR | 1 |
15 other study(ies) available for bw a1433u and adenosine
| Article | Year |
|---|---|
Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Cats; Dinoprost; GTP-Binding Proteins; Indomethacin; Methoxamine; Pertussis Toxin; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Quinoxalines; Signal Transduction; Thromboxane A2; Virulence Factors, Bordetella; Xanthines | 1992 |
Adenosine and ATP produce vasoconstriction in the feline pulmonary vascular bed by different mechanisms.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cats; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturated; Hydrazines; Lung; Meclofenamic Acid; Phenylisopropyladenosine; Purinergic Antagonists; Receptors, Prostaglandin; Receptors, Purinergic; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction; Vasodilator Agents; Xanthines | 1991 |
Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface.
Topics: Actins; Adenosine; Adenosine Deaminase; Cell Movement; Chemotaxis, Leukocyte; Cyclic AMP; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Pentoxifylline; Receptors, Purinergic; Recombinant Proteins; Tumor Necrosis Factor-alpha; Xanthines | 1990 |
Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction. Mechanism and physiological implications.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Atrioventricular Node; Bundle of His; Depression, Chemical; Dipyridamole; Female; Guinea Pigs; Heart Atria; Heart Block; Heart Rate; Hypoxia; Male; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Xanthines | 1990 |
Human retinal pigment epithelial cells in culture possess A2-adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclases; Cell Count; Cells, Cultured; Cyclic AMP; Humans; Pigment Epithelium of Eye; Receptors, Purinergic; Second Messenger Systems; Xanthines | 1989 |
Role of endogenous adenosine in postdefibrillation bradyarrhythmia and hemodynamic depression.
Topics: Adenosine; Animals; Atrioventricular Node; Blood Pressure; Bradycardia; Dipyridamole; Electric Countershock; Female; Hemodynamics; Male; Methoxamine; Sinoatrial Node; Swine; Xanthines | 1989 |
Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation.
Topics: Adenosine; Adenosine Deaminase; Adenylate Cyclase Toxin; Animals; Cell Line; Cyclic AMP; Inositol Phosphates; Pertussis Toxin; Phenylisopropyladenosine; Prolactin; Rats; Receptors, Purinergic; Sugar Phosphates; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured; Virulence Factors, Bordetella; Xanthines | 1988 |
Antagonism of the effects of adenosine and hypoxia on atrioventricular conduction time by two novel alkylxanthines: correlation with binding to adenosine A1 receptors.
Topics: Adenosine; Animals; Guinea Pigs; Heart Conduction System; Hypoxia; In Vitro Techniques; Receptors, Purinergic; Time Factors; Xanthines | 1987 |
Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
Topics: Adenosine; Animals; Antihypertensive Agents; Cells, Cultured; Glucose; Myocardial Infarction; Myocardial Ischemia; Myocardium; Naphthalenes; Phenethylamines; Phenylisopropyladenosine; Polycyclic Compounds; Protein Kinase C; Purinergic Antagonists; Pyruvates; Pyruvic Acid; Rabbits; Receptors, Purinergic P1; Theophylline; Time Factors; Trypan Blue; Xanthines | 1994 |
Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.
Topics: Adenosine; Animals; Antihypertensive Agents; Female; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Perfusion; Purinergic Antagonists; Rabbits; Receptors, Purinergic P1; Theophylline; Xanthines | 1994 |
Attenuation of postischaemic dysfunction by ischaemic preconditioning is not mediated by adenosine in the isolated rat heart.
Topics: Adenosine; Animals; Blood Pressure; Heart Rate; Lactates; Lactic Acid; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phenylisopropyladenosine; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Xanthines | 1993 |
Effects of adenosine antagonists on hexose uptake and preconditioning in perfused rat heart.
Topics: Adenosine; Animals; Deoxyglucose; Hexoses; In Vitro Techniques; Male; Myocardial Stunning; Myocardium; Perfusion; Purines; Rats; Rats, Sprague-Dawley; Sulfonamides; Xanthines | 1993 |
Adenosine increases lactate release and delays onset of contracture during global low flow ischaemia.
Topics: Adenine; Adenosine; Animals; Glucose; Lactates; Lactic Acid; Male; Myocardial Contraction; Myocardial Ischemia; Rats; Rats, Wistar; Xanthines | 1993 |
Inhibition of glucose transport in human red blood cells by adenosine antagonists.
Topics: Adenosine; Biological Transport; Deoxyglucose; Erythrocytes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetics; Models, Biological; Xanthines | 1997 |
Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation.
Topics: Adenosine; Adenylyl Cyclases; Animals; Anti-Arrhythmia Agents; Binding, Competitive; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Hydroxy Acids; Hypoglycemic Agents; Myocardial Reperfusion Injury; Myocardium; Perfusion; Potassium Channels; Rabbits; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines | 1998 |